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Dr. Melvin Marcus and I thought that it would be appropriate to bring together a number of active investigators in this area of research to reexamine in depth the cerebral vascular effects of nerves and neurotransmitters. There were several reasons to think that a symposium would be timely. First, there have been important recent advances in un derstanding cellular mechanisms of cerebral ves sels. Second, a systematic examination of cerebral vascular effects of neurotransmitters has led to a consensus in some areas. Third, recent evidence has resolved some of the controversy concerning effects of sympathetic nerves on cerebral vessels. Fourth, studies in vitro and in vivo concerning the role of vasodilator mechanisms have resulted in conflicting results, for reasons that are unclear. Fifth, the role of central neural pathways in the reg ulation of cerebral blood flow remains unsettled. The studies of central pathways, which are difficult and challenging, require careful examination and cautious interpretation.
The symposium was planned by an organizing committee that was diverse in terms of area of interests and geography. The committee members were Drs. John Bevan, Murray Harper, Donald Heistad, Hermes Kontos, Niels Lassen, Melvin Marcus, Christer Owman, Michael Purves, Donald Reis, and Jacques Seylaz. A book that summarizes the presentations at the symposium will be pub lished by Elsevier Publishing Co. in early 1982.
I will summarize a few of the topics that were discussed at the symposium and give a rather per sonal view of the status of research concerning the effects of nerves and neurotransmitters on the cere bral circulation.
Cellular Mechanisms
Studies in the past two years by N. Lusamvuku, J. Seylaz and his colleagues (Paris), and K. Hermsmeyer et al. (Iowa City) have provided the first data concerning electrogenic mechanisms in cerebral vessels. A paper by Dr. Hermsmeyer de scribed membrane and mechanical effects of nor epinephrine and histamine. A surprising finding was that low doses of norepinephrine produce hyper polarization and relaxation of cat pial arteries, in contrast to the expected contraction (and depolari zation) recorded in basilar arteries. Hyperpolariza tion and relaxation of the pial artery was blocked by propranolol. There have been conflicting views about the role of f:1-adrenergic mechanisms in cere bral vessels. This study provides interesting new data concerning possible f:1-adrenergic effects.
There has been important recent progress in our understanding of the role of extracellular and in tracellular calcium in cerebral vasoconstrictor re sponses. Drs. McCalden and J. Bevan (Houston and Los Angeles) reported that the tonic contractile response of basilar artery to norepinephrine is al most totally dependent on influx of extracellular calcium. In contrast, release of intracellular calcium contributes to tonic contraction of the basilar artery in response to serotonin. In addition, release of in tracellular calcium contributes to contraction of the ear artery in response to both norepinephrine and serotonin. The authors speculated that the relative insensitivity of the basilar artery to norepinephrine may be due in part to the unusual receptor contraction coupling mechanism.
Drugs that block calcium channels have been useful in studies of basic mechanisms of contraction in cerebral vessels. Drs. R. Towart and S. Kazda (Wuppertal), presented evidence that nimodipine is much more potent in inhibition of amine-induced contractions in basilar artery than in saphenous ar tery. In contrast, nimodipine is equipotent in inhi bition of potassium or barium contraction in basilar and saphenous arteries. The greater potency of nimodipine in inhibition of catecholamine-induced contractions in basilar artery may be related to de pendence of the basilar artery on extracellular cal cium, as shown by Drs. McCalden and Bevan. The therapeutic implications of selective inhibition of contraction in cerebral arteries are attractive.
Neurotransmitters Dr. C. Owman (Lund) reviewed a series of studies which indicate that the blood-brain barrier is constituted by enzymatic as well as structural mechanisms. Monoamines are trapped by enzy matic mechanisms in endothelial cells and peri cytes. A point that was discussed is the vascular segment at which barrier mechanisms are estab lished in cerebral vessels. The barrier apparently is not present in the middle cerebral artery; it is pres ent in intraparenchymal arteries; but Dr. Owman suggests that it may not be fully developed in pial arteries. Although the barrier to albumin, horse radish peroxidase, and barium chloride is present in pial arteries, it is possible that the barrier to other substances (including monoamines) may not be fully developed.
Dr. R. Dacey (Charlottesville) described a re markable method that he and Dr. B. Duling have developed to study cer-ej)ral microvessels. In traparenchymal cerebral arteriQles (mean diameter, 26 fLm) are cannulated with a pipette and perfused in vitro. The arterioles developed spontaneous tone, as diameter decreased by almost 30% when the ves sels were inflated to 60 mm Hg. The authors found that pH had a marked effect on vasoconstrictor re sponses to norepinephrine. Norepinephrine did not constrict the vessels at a pH of 7.30 but produced
pronounced vasoconstriction when pH was 7.80. These observations confirm earlier findings in pial vessels by Dr. H. Kontos.
The tight coupling of cerebral metabolism and blood flow is preserved during infusion of catechol amines. Dr. J. McCulloch (Glasgow) demonstrated that the dopaminergic agonist apomorphine pro duces focal increases in glucose utilization and parallel increases in blood flow. Dr. McCulloch con cluded that metabolic, rather than direct vascular, mechanisms were the primary determinants of cere bral perfusion after administration of apomorphine. Dr. W. Kuschinsky (Munich), working in Dr. Soko loffs laboratory (Bethesda), reported tight coupling between cerebral glucose utilization and blood flow during the intravenous infusion of norepinephrine. The slope of the relationship between glucose utilization and flow, however, was altered, which suggests that norepinephrine resets the coupling mechanism.
There have been a large number of excellent studies in the past few years concerning cerebral vascular and metabolic effects of catecholamines. These studies have resulted in considerable prog ress in the area.
Sympathetic Nerves
A number of investigators who attended the sym posium have made major contributions in the steady progress towards understanding the role of sympa thetic nerves in the cerebral circulation. A major advance was the study by Bill and Linder (1976) demonstrating that electrical stimulation of sympa thetic nerves attenuates increases in cerebral blood flow during acute severe hypertension. The finding is of central importance because it demonstrated convincingly a potentially important role of nerves in the regulation of cerebral blood flow. If important effects can be demonstrated under less extreme conditions, we will have made major progress in understanding the physiological function of sym pathetic innervation of cerebral vessels.
Autoregulation normally maintains cerebral blood flow relatively constant over the physiologi cal range of arterial pressure. After sudden in creases in pressure within this range, however, there is a transient increase in cerebral blood flow. Drs. D. Busija, Marcus, and I have demonstrated that electrical stimulation of sympathetic nerves attenuates the transient increase in cerebral blood flow. Dr. S. Vatner (Boston) presented evidence that when arterial pressure is raised abruptly by stimulation of chemoreceptors, reflex increases in sympathetic tone reduce the transient increase in cerebral blood flow. Thus, previous studies demon strated that sympathetic nerves protect cerebral vessels during severe increases in arterial pressure; these studies demonstrate that either electrical or reflex sympathetic stimulation attenuates passive increases in cerebral blood flow within the physio logical range of arterial pressure.
Dr. E. MacKenzie and colleagues in Glasgow ex amined effects of lesions of the nucleus tractus sol itarius (NTS). Lesions of the NTS produce intense sympathetic discharge and fulminating hyperten sion. They found increases in blood flow and dis ruption of the blood-brain barrier in the arterial boundary zones. It seems that this area is suscepti ble to acute hypertension as well as hypotension.
Drs. M. Hart, M. Brody, and I have demon strated that sympathetic nerves promote develop ment of cerebral vascular hypertrophy during chronic hypertension. Drs. S. Sadoshima, D. Busija, M. Brody, and I have tested the hypothesis that sympathetic nerves protect against stroke in stroke-prone spontaneously hypertensive rats. Sympathetic nerves to one cerebral hemisphere were interrupted when rats were 3 -4 weeks old, and nerves to the other hemisphere remained intact. The striking finding was that virtually all of the strokes in these rats occurred in the denervated ce rebral hemisphere. Thus, sympathetic nerves con tribute to cerebral vascular hypertrophy and protect against stroke in hypertensive rats.
Vasodilator Mechanisms
During the many years before an important physiological role of sympathetic nerves was dem onstrated, a fact that sustained interest in this area was that cerebral vessels have dense sympathetic innervation. Intuitively, it seemed likely that a functional role of the sympathetic innervation would be found. The current status of studies con cerning cholinergic and other vasodilator mecha nisms is analogous.
Nerve stimulation produces relaxation of cerebral arteries of the cat in vitro. It has been remarkably difficult to determine which neurotransmitter mediates this response. Two excellent laboratories have obtained conflicting results. Dr. J. Bevan (Los Angeles) presented evidence that atropine at tenuates neurogenic vasodilatation of cerebral arteries in vitro. Dr. S. Duckles (Tucson) reported that cerebral arteries contain high levels of acetylcholine and that acetylcholine is released by neural stimu lation in vitro. She reported, however, that inhibi tion of release of acetylcholine by f3-bungarotoxin does not reduce cerebral vasodilator responses to neural stimuli and that atropine does not inhibit the response. Thus, it is not yet established whether acetylcholine is an important transmitter for cere bral vasodilatation during neural stimuli.
Vasoactive intestinal peptide (VIP) is present in nerves to cerebral arteries. Dr. Duckles reported, in a study with Dr. S. Said, that levels of VIP are high in cerebral arteries and that the levels correlate with vasodilator responses in vitro. Dr. Bevan described preliminary results indicating that VIP antibody greatly reduces cerebral vasodilator responses to exogenous VIP and to neural stimulation in vitro. These findings suggest that VIP may be an impor tant neurotransmitter in cerebral resistance vessels. Much more evidence is needed to clarify the role of VIP.
Concerning the functional role of vasodilator mechanisms, one might predict that neural factors contribute to steady-state vasodilatation during hypoxia, hypotension, or hypercapnia, or that nerves accelerate the response to these stimuli. This hypothesis, however, has not yet been supported by convincing experimental evidence. Dr. R. Trayst man (Baltimore) presented additional studies that suggest that arterial chemoreceptors do not con tribute to cerebral vasodilation during hypoxia. Studies by Dr. J. Hardebo et al. (Lund) and in our laboratory indicate that atropine does not attenuate cerebral vasodilatation during hypercapnia.
Two of the fundamental questions that remain unanswered in this area of research are, first, what is the primary neurotransmitter that mediates dila tation of cerebral vessels? And, second, what is the physiological role of neural vasodilator mechanisms in the cerebral circulation?
Central Pathways
Several provocative studies have suggested that vasomotor nerve fibers originate in the brainstem and influence cerebral blood flow. The locus coeruleus has received particular attention. At the symposium, however, there was little support for the concept that locus coeruleus pathways affect cerebral blood flow directly (i.e., as opposed to in-direct effects mediated by changes in cerebral me tabolism). Dr. Owman pointed out that although there is evidence for innervation of cerebral capil laries, no one has seen morphological evidence for brainstem innervation of resistance vessels. Dr. McCulloch presented evidence that unilateral le sions of the locus coeruleus do not alter cerebral blood flow. Dr. M. Harper (Glasgow) summarized evidence obtained by Dr. Dahlgren and his as sociates (Lund) that chronic lesions of the locus coeruleus do not affect cerebral blood flow during normocapnia or hypercapnia. I agree with a state ment by Dr. Kontos (Richmond) that evidence against a role for the locus coeruleus is at least as good as evidence for a role.
It also has been suggested that the locus coeruleus may have direct effects on permeability of cerebral capillaries. Dr. McCulloch reported at the symposium, however, that lesions of the locus coeruleus do not affect capillary permeability. His studies, and earlier studies, examined PS product (capillary permeability x surface area), and Dr. McCulloch proposed that effects of locus coeruleus on PS product may be produced by changes in capillary surface area rather than permeability. Thus, effects of the locus coeruleus on capillary permeability, as well as on cerebral blood flow, are controversial at this time.
Drs. D. Reis and C. ladecola (New York) con trasted effects of stimulation in two areas of the brain. Stimulation of the medullary reticular forma tion increases cerebral metabolism and produces the expected secondary increase in blood flow. In contrast, stimulation of the fastigial nucleus of the cerebellum increases blood flow without a detect able increase in cerebral metabolism. This finding suggests a direct vascular effect of fastigial stimula tion. One must be cautious in interpretation of these findings, because blood flow was measured a few minutes after beginning the stimulation, whereas cerebral oxygen consumption was measured for a 45-minute period of stimulation. Thus it is possible that metabolism, as well as blood flow, was in creased during the early period of stimulation. The study is nevertheless provocative and should en courage further work in the area. My view is that there has been major progress in the past few years concerning cerebral vascular ef fects of neurotransmitters and sympathetic nerves. This progress is related in part to improved methods for measurement of cerebral metabolism and blood flow. In contrast, progress towards understanding the physiological role of vasodilator pathways and of central pathways has been slow. There is uncer tainty about anatomical pathways that may mediate these responses and there are many factors (e.g., changes in cerebral metabolism or arterial pressure) that complicate interpretation of the results. This area of research is likely to continue to be chal lenging.
